Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

244 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical and pharmacokinetic study of docetaxel in elderly non-small-cell lung cancer patients.
Takigawa N, Segawa Y, Kishino D, Fujiwara K, Tokuda Y, Seki N, Shinkai T, Watanabe Y, Hiraki S, Kozuki T, Gemba K, Tabata M, Kiura K, Ueoka H, Tanimoto M. Takigawa N, et al. Among authors: hiraki s. Cancer Chemother Pharmacol. 2004 Sep;54(3):230-6. doi: 10.1007/s00280-004-0826-x. Epub 2004 May 4. Cancer Chemother Pharmacol. 2004. PMID: 15127232 Clinical Trial.
A phase III randomized trial comparing vindesine and cisplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer: long-term follow-up results and analysis of prognostic factors.
Kodani T, Ueoka H, Kiura K, Tabata M, Takigawa N, Segawa Y, Moritaka T, Hiraki S, Harada M, Tanimoto M. Kodani T, et al. Among authors: hiraki s. Lung Cancer. 2002 Jun;36(3):313-9. doi: 10.1016/s0169-5002(02)00008-9. Lung Cancer. 2002. PMID: 12009244 Clinical Trial.
[Combination chemotherapy with carboplatin and etoposide for elderly patients aged 76 years or older with small cell lung cancer].
Tada A, Ueoka H, Kiura K, Tabata M, Takemoto M, Yamane H, Hiyama J, Aoe K, Shibayama T, Kamei H, Kawahara S, Harita S, Sato T, Kobayashi M, Eguchi K, Hiraki S, Hiraki Y, Tanimoto M. Tada A, et al. Among authors: hiraki s, hiraki y. Gan To Kagaku Ryoho. 2002 May;29(5):751-6. Gan To Kagaku Ryoho. 2002. PMID: 12040679 Clinical Trial. Japanese.
Phase I/II study of altered schedule of cisplatin and etoposide administration and concurrent accelerated hyperfractionated thoracic radiotherapy for limited-stage small-cell lung cancer.
Segawa Y, Ueoka H, Kiura K, Tabata M, Takigawa N, Hiraki Y, Watanabe Y, Yonei T, Moritaka T, Hiyama J, Hiraki S, Tanimoto M, Harada M; Okayama Lung Cancer Study Group. Segawa Y, et al. Among authors: hiraki s, hiraki y. Lung Cancer. 2003 Jul;41(1):13-20. doi: 10.1016/s0169-5002(03)00139-9. Lung Cancer. 2003. PMID: 12826307 Clinical Trial.
A triplet chemotherapy with cisplatin, docetaxel and gemcitabine in patients with advanced non-small-cell lung cancer: a phase I/II study.
Tabata M, Kozuki T, Ueoka H, Kiura K, Harita S, Tada A, Shibayama T, Takigawa N, Yonei T, Gemba K, Segawa Y, Kishino D, Tada S, Hiraki S, Tanimoto M; Okayama Lung Cancer Study Group. Tabata M, et al. Among authors: hiraki s. Cancer Chemother Pharmacol. 2007 Jun;60(1):53-9. doi: 10.1007/s00280-006-0346-y. Epub 2006 Sep 29. Cancer Chemother Pharmacol. 2007. PMID: 17009034 Clinical Trial.
A randomized trial of hybrid administration of cyclophosphamide, doxorubicin, and vincristine (CAV)/cisplatin and etoposide (PVP) versus sequential administration of CAV-PVP for the treatment of patients with small cell lung carcinoma: results of long term follow-up.
Ueoka H, Kiura K, Tabata M, Kamei H, Gemba K, Sakae K, Hiraki Y, Hiraki S, Segawa Y, Harada M. Ueoka H, et al. Among authors: hiraki s, hiraki y. Cancer. 1998 Jul 15;83(2):283-90. Cancer. 1998. PMID: 9669811 Clinical Trial.
244 results